Protagonist Therapeutics, Inc Quarterly Marketable Securities, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Protagonist Therapeutics, Inc quarterly Marketable Securities, Current history and growth rate from Q4 2018 to Q2 2024.
  • Protagonist Therapeutics, Inc Marketable Securities, Current for the quarter ending June 30, 2024 was $208M, a 167% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $208M +$130M +167% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $150M +$47M +45.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $155M +$43.3M +38.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $90.2M -$24.4M -21.3% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $78M -$93.6M -54.5% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $103M -$104M -50.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $112M -$91.6M -45.1% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $115M -$79.1M -40.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $172M +$9.79M +6.05% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $207M +$16.3M +8.58% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $203M +$14.8M +7.85% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $194M +$83.4M +75.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $162M +$99.4M +159% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $190M +$133M +232% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $188M +$88.4M +88.4% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $110M +$22.9M +26.1% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $62.4M +$7.47M +13.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $57.3M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $100M +$53.4M +115% Dec 31, 2019 10-K 2021-03-10
Q3 2019 $87.5M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $55M Jun 30, 2019 10-Q 2019-08-07
Q4 2018 $46.6M Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.